PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Pharmacy, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.\', \'Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.\', \'Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.\', \'Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA, ejabbour@mdanderson.org.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1159/000508199
?:doi
?:hasPublicationType
?:journal
  • Acta haematologica
is ?:pmid of
?:pmid
?:pmid
  • 32392559
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.575
?:rankingScore_hIndex
  • 53
is ?:relation_isRelatedTo_publication of
?:title
  • Treating Leukemia in the Time of COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32392559>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32392559>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all